PPBT (Purple Biotech) FCF Margin %: 0.00% (As of Mar. 2026)


PPBT Purple Biotech Ltd PPBT
25 GF Score
Price $1.63
! 2 Warning Signs
View Full Analysis

What is Purple Biotech FCF Margin %?

Purple Biotech PPBT -2.98% 25 FCF Margin % is 0.00% as of Mar. 2026. GuruFocus rates PPBT with a GF Score™ of 25/100. The stock has 2 warning signs investors should review. Among 957 Biotechnology companies, Purple Biotech ranks worse than 104493.1% on this metric.

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Purple Biotech's Free Cash Flow for the three months ended in Mar. 2026 was $-3.12 Mil. Purple Biotech's Revenue for the three months ended in Mar. 2026 was $0.00 Mil. Therefore, Purple Biotech's FCF Margin % for the quarter that ended in Mar. 2026 was 0.00%.

As of today, Purple Biotech's current FCF Yield % is -112.16%.

The historical rank and industry rank for Purple Biotech's FCF Margin % or its related term are showing as below:


During the past 13 years, the highest FCF Margin % of Purple Biotech was -849.49%. The lowest was -8651.01%. And the median was -4750.25%.

PPBT's FCF Margin % is not ranked *
in the Biotechnology industry.
Industry Median: -84.65
* Ranked among companies with meaningful FCF Margin % only.

Purple Biotech FCF Margin % Related Terms

Purple Biotech FCF Margin % Historical Data

* Premium members only.

The historical data trend for Purple Biotech's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Purple Biotech FCF Margin % Chart

Purple Biotech Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
FCF Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Purple Biotech Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
FCF Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

PPBT vs VRTX, REGN, ALNY: FCF Margin % Comparison

For the Biotechnology subindustry, Purple Biotech's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Purple Biotech FCF Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Purple Biotech's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Purple Biotech's FCF Margin % falls into.


PPBT
25GF Score
Purple Biotech Ltd PPBT
FCF Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Purple Biotech FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Purple Biotech's FCF Margin for the fiscal year that ended in Dec. 2025 is calculated as

FCF Margin=Free Cash Flow (A: Dec. 2025 )/Revenue (A: Dec. 2025 )
=-5.659/0
= %

Purple Biotech's FCF Margin for the quarter that ended in Mar. 2026 is calculated as

FCF Margin=Free Cash Flow (Q: Mar. 2026 )/Revenue (Q: Mar. 2026 )
=-3.121/0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about FCF Margin % →
What does a FCF Margin % of 0.00% mean?
Purple Biotech (PPBT) has a FCF Margin % of 0.00% as of Mar. 2026. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Purple Biotech and its competitors. According to the industry distribution chart, Purple Biotech ranks #999999 out of 957 companies in the Biotechnology industry.
Is Purple Biotech's FCF Margin % too high?
Purple Biotech's current FCF Margin % is 0.00%. Based on the distribution chart, Purple Biotech ranks #999999 out of 957 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, Purple Biotech has a GF Score™ of 25/100, reflecting its overall financial health beyond just this single metric.
How does Purple Biotech's FCF Margin % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Purple Biotech ranks #999999 out of 957 companies for FCF Margin %. This places Purple Biotech in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Biotechnology company?
A good FCF Margin % depends on the Biotechnology industry context. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Purple Biotech and its competitors. Purple Biotech's current FCF Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Purple Biotech stock overvalued right now?
Purple Biotech (PPBT) has a current FCF Margin % of 0.00%. The current FCF Margin % is 0.00%. Purple Biotech's overall GF Score™ is 25/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For Purple Biotech (PPBT), the current FCF Margin % is 0.00% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Purple Biotech Business Description

Other Exchanges PPBT:Israel
Address 4 Oppenheimer Street, Science Park, Rehovot, ISR, 7670104
Purple Biotech Ltd is a clinical-stage biotechnology company focused on the development and commercialization of pharmaceuticals. It currently have a preclinical tri-specific antibodies platform, CAPTN-3, with its therapeutic candidates, IM1240 and IM1305, and two other oncology therapeutic candidates that are in the clinical trial phase, CM24 and NT219, neither of which has been approved for marketing and are not being sold, marketed, or commercialized.
25GF Score

Get the complete analysis for PPBT

FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$1.63
Price